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4.—The rapid decline of strong anti-German feelings at the Institut Pasteur.
ABSTRACT: The development of anti-diphtheria serotherapy at the Institut Pasteur immedia-
tely follows the crisis known as the Pasteur-Koch debate. Research on diphtheria in Paris is 
indicative of the importance granted by Pasteurian scientists to Koch’s school criticisms. After 
1887, relations between French and German bacteriologists become more relaxed. A scientific 
and social network develops between them. It later extends to other fields of research at the 
Institut Pasteur, particularly therapeutic chemistry. The evolution of Franco-German relations 
at the Institut Pasteur is placed in the general framework of the way French universities con-
sidered German science.
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1. Introduction
A violent debate between Louis Pasteur (1822-1895) and Robert Koch (1843-
1910) broke out in 1881 on the issue of the vaccination against anthrax soon 
after the International Congress of Medicine in London held in August of 
that year. It became openly aggressive after the IV International Congress for 
Hygiene and Demography (Geneva, September 1882). Koch’s and Loeffler’s 
criticisms, not to say indictment, were actually directed against the entire 
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methodological approach of Pasteur to microbes, microbial diseases and 
induction of a refractory condition and in fine to the validity of the results. 
The Koch-Pasteur debate, the differences in procedures in Pasteur’s and 
Koch’s laboratories, have been studied extensively elsewhere,  and will not 
be examined once more  1. The main methodological questions raised by 
Koch in his 1882 paper 2 as summarized in 1883 by distant observers 3, were: 
claim of the priority of discovery; questioning of the purity of the bacteria 
used to prepare the vaccine; questioning of the existence of «general laws» 
of attenuation; abusive generalization of the results of some experiments; 
abusive publicity given to the anthrax vaccine; strong doubts concerning 
the efficacy and reproducibility of the vaccine and the secrecy kept on 
preparation protocols. Several non-scientific reasons are very likely to have 
boosted the bitterness of the dispute. They are certainly rooted in Koch’s 
and Pasteur’s strong respectively anti-French and anti-German feelings 4, 
and also in the economic interests involved in the success or failure of 
vaccination of cattle against anthrax 5.
The important point for us lies in the fact that the Pasteur-Koch debate 
was the first critical discussion of the definitions and methods to be used 
to identify microbes, prove their role in causing diseases and combating 
 1. SALOMON-BAYET, Claire. Pasteur et la revolution pasteurienne, Paris, Payot, 1998; CARTER, K. Codell. 
The rise of causal concepts of disease: case histories, Burlington, Ashgate, 2003; GEISON, Gerald. 
The private science of Louis Pasteur, Princeton, Princeton University Press, 1995; GRADMANN, 
Christoph. Krankheit im Labor. Robert Koch und die medizinische Bakteriologie, Göttingen, 
Wallstein Verlag, 2005; MOULIN, Anne-Marie. Le dernier langage de la médecine: histoire de 
l‘immunologie, de Pasteur au Sida, Paris, PUF, 1991; BROCK, T. D. Robert Koch: a life in medicine 
and bacteriology, Washington, ASM Press, 1998; CARTER, K.C. The Koch-Pasteur dispute on 
establishing the cause of anthrax. Bull. Hist. Med., 1988, 62, 42-57. A recent English version 
of the main papers by Koch and by Pasteur dealing with the dispute over anthrax can be 
downloaded from www.foundersof science.net
 2. Translated in CARTER, K. C. Essays of Robert Koch, New York, Greenwood Press, 1987.
 3. Dr Robert Koch latest estimate of Pasteur’s methods and discoveries and the present position of 
the general inoculation problem. Editorial. Boston Medical and Surgical Journal, 1883, 108 (3), 
January 18. The answer of Pasteur to Koch is published in the same journal, ( 9, March 1). 
 4. For a discussion of the context by a close witness, on the Pasteur side, of the Koch-Pasteur 
dispute, see METCHNIKOFF, Elya. Trois fondateurs de la médecine moderne Lister, Pasteur et Koch, 
Paris, Felix Alcan, 1933.
 5. Anthrax, or charbon in French, is an infectious disease caused by a sporulating bacterium, 
Bacillus anthracis. The disease exists in animals and humans. In the absence of vaccination, 
the death toll of the disease is about 10% among cattle. This explains in part why discussions 
about the efficacy of the vaccine were dominated by economics: to be useful, vaccination 
of cattle had to decrease animals’ death toll to below 1-2%. 
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the latter. Actually, and whatever the response of Pasteur himself to Koch 
could have been 6, criticisms of Pasteur’s methods were not ignored by 
French microbiologists, although their work, including vaccination against 
rabies in 1885, somehow continued along their former methodological 
scheme. In that respect, the development of research on diphtheria in 
France after 1888 illustrates a movement away from the criticized Pasteur’s 
methods. The work on diphtheria at the Institut Pasteur indeed appears 
to have developed in a manner indicating an underlying will to avoid the 
kind of criticisms raised against the anti-anthrax and anti-rabies vaccines. 
Actually, it also served the introduction of a culture of the norm and of 
quantification at the Institut Pasteur, in a scientific context which very 
rapidly lost most of its initial hostile feeling and instead has to be placed 
in the context of a kind of race between French and German scientists 7. 
The aim of the present paper is thus to examine, by studying the diphtheria 
case, the influence German microbiology had on scientific procedures and 
attitudes at the Institut Pasteur.
2.  Shuttling of research on diphtheria between France and Germany
Diphtheria is an illness affecting the upper respiratory tract, the noso-
graphy of which is described and the disease named (diphtérite) in 1826 
by the French physician P. Bretonneau 8. Diphtheria is characterized by 
sore throat, fever, and the progressive development, on the tonsils and the 
pharynx, of membranes adherent to mucosa, which in the most severe 
cases, leads to the obstruction of airways and suffocation. Diphtheria is a 
highly contagious disease spread by infected individuals, and is associated 
with epidemic outbreaks. During the 1888-1894 period, diphtheria was 
 6. PASTEUR, Louis. La vaccination contre le charbon. La Revue Scientifique, 20 janvier 1883.
 7. WEINDLING, Paul. From medical research to clinical practice: serum therapy for diphtheria 
in the 1890s. In: PICKSTONE John V. (Ed.), Medical innovations in historical perspective, New 
York, St Martin’s Press, 1992, pp. 72-83; and  WEINDLING, P. Scientific elites and laboratory 
organisation in fin de siècle Paris and Berlin. The Pasteur Institute and Robert Koch Institute 
for Infectious Diseases compared. In: A. Cunningham and P. Williams (Eds.), The laboratory 
revolution in medicine, Cambridge, Cambridge University Press, 1992, pp. 170-188.
 8. BRETONNEAU, Pierre-Fidèle. Des inflammations spéciales du tissu muqueux, et en particulier de la 
diphtérite, ou inflammation pelliculaire, connue sous le nom de croup, d’angine maligne, d’an-
gine gangréneuse, etc, Paris, Crevot , 1826 (available on line at the Bibliothèque Nationale de 
France).
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responsible for an average annual death toll of 6-7 per 10,000 persons in 
Europe 9. Mortality could reach 80 % in children under 10. Consequently, 
the disease and particularly the suffocating form of diphtheria often obser-
ved in children (named the «croup») inspired much fear among parents. 
As for rabies, diphtheria was not only a deadly disease; it was also a highly 
significant social target for researchers 10. 
Before the introduction of specific antidiphtheria serotherapy in 1894, 
treatment of diphtheria chiefly consisted of the disinfection of the throat in 
attempts to kill bacteria and dislodge membranes. One of the first effective 
treatments, introduced in the 1880s was the insertion of tubes into the 
throat through the membranes, to prevent victims from suffocating. In 
the most severe cases, tracheotomy was performed 11. That therapeutic 
strategy, associated with hygienic procedures and disinfection, was in 
use in 1890  12. The same procedures later remain in use as adjuvant to 
serotherapy 13. 
The causative agent of diphtheria is Corynebacterium diphtheriae 
(Klebs-Loeffler bacillus), a bacillus first identified in 1883 by E. Klebs 
(1834-1912) in throat lesions of patients and grown in vitro by F. Loeffler 
(1852-1915) in 1884, two German bacteriologists. The first period of active 
research on diphtheria at the Institut Pasteur (1888-1889) corresponds to 
the demonstration by E. Roux (1853-1933) that the Klebs-Loeffler bacillus 
is the genuine and only cause of diphtheria 14 (thus meeting the require-
ment of «one bacterial species-one disease» and that of purity of bacterial 
strains emphasized by Koch). Major scientific breakthroughs are made in 
Germany at the same moment: the bacteria responsible for two major hu-
man infectious diseases, diphtheria and tetanus, are proved to act through 
the soluble toxins they release in infected organisms. E.von Behring (1854-
 9. WEISSENFELD, J. Die Veränderungen der Sterblichkeit an Diphterie und Schralach, Centralblatt 
für allgemeine Gesundheitspflege, 1900, p. 318, cité dans la revue des journaux par RENAUD, 
F. H. La Revue d’hygiène et de police sanitaire, 1900, 22, 955-956.
 10. The success of the anti-diphtheria serum was largely divulged in France through engravings 
printed on the front page of newspapers in September 1894, just as for rabies.
 11. BOURGES, Henri. La diphtérie, Paris, Bibliothèque médicale Charcot-Debove, 1892. 
 12. OPINEL, Annick. The Pasteur hospital as an element of Emile Roux’s anti-diphtheria apparatus 
(1890-1914). Dynamis, present issue.
 13. SEVESTRE, L.; MARTIN, Louis. Diphtérie. In: Traité des maladies de l’enfance, Paris, Masson et fils, 
1896. vol. 1, pp. 616-623 (local treatment) and 655-705 (surgical treatment). 
 14. ROUX Emile; MARTIN Louis. Contribution à l’étude de la diphtérie. Annales de l’Institut Pasteur, 
1888, 2 (12), 629-661.
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1917) and S. Kitasato (1852-1931) demonstrate that protection against 
the toxin can be induced by injecting the latter into the proper recipient 
animals. Protection is associated with the serum of immunized animals 
and, more importantly, is transferable to other animals. This is followed 
by showing that the symptoms of the disease can be induced by injecting 
animals with the toxin alone. A year later, Roux and Yersin detail the 
properties of the toxin, show it has the features of a diastase, and confirm 
that immunity against the toxin can be induced 15, as it can against other 
soluble molecules. A therapeutic (still confused with prevention) target is 
thus identified, different from the bacterium proper: neutralization of the 
toxin by a serum, instead of attempts at killing bacteria, is now searched 
for in both countries.
Another important move takes place around 1890 with Roux’s decision 
to carry out systematic bacteriological diagnosis in patients suspected of 
suffering from diphtheria. Indeed, physicians were facing difficulties in 
diagnosing «genuine diphtheria» because of the heterogeneity of the clini-
cal signs displayed by patients, thus leading to erratic diagnoses. Also the 
presence of other bacteria, such as staphylococci and streptococci, could 
influence the outcome of the illness. The introduction of bacteriological 
testing of diphtheria had two main consequences: one was clinical in na-
ture, namely concerning prognosis and monitoring of the presence of the 
bacterium during the evolution of the disease; the second was statistical, 
enabling the sorting of patients into better defined, more homogeneous, 
groups. Only patients suffering from proven diphtheria were retained for 
subsequent clinical trials. That group was further subdivided into two 
sub-groups, those with diphtheria bacilli alone and those with diphtheria 
bacilli associated with other pathogens, an association found to result in 
a poor prognosis 16. In modern statistical terms, this means that diphthe-
ria cases could now be organized into defined cohorts, enabling a more 
reasonable statistical approach. Bacteriological diagnosis was carried out 
in a laboratory implemented in the Hôpital des Enfants-malades by Louis 
 15. ROUX, Emile; YERSIN, Alexandre. Contribution à l’étude de la diphtérie. 2e mémoire. Annales de 
l’Institut Pasteur, 1889, 3 (6), 273-288.
 16. ROUX, Emile; YERSIN, Alexandre. Contribution à l’étude de la diphtérie. 3e mémoire. Annales de 
l’Institut Pasteur, 1890, 4 (7), 384-426.
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Martin (1864-1946), a physician selected by Roux among Grancher’s 17 
students. 
The ping-pong process between France and Germany persists. Between 
1890 and 1892, Wernicke and Behring, following studies of serum transfer 
into infected animals, describe the cure of three diphtheria cases in children 
by injection of the serum of dogs that have survived experimental diphthe-
ria. The strategy German scientists use is known and discussed in France 
before their final publication in 1893 18. Thus the serum of immunized 
animals can neutralize the toxin and contribute to curing the patients. The 
above-mentioned results initiate competition for both the most efficient 
production of anti-diphtheria serum usable in humans and for protocols 
of testing. In contrast with earlier experiments, the procedures, the data 
and the discussion are now given in great detail in the 1894 paper which 
accompanies the first French large-scale test on children. Before being 
injected into the serum-producing animals, the toxin has to be produced 
and inactivated. The Pasteur team is expert in defining the conditions 
of bacterial growth and toxin secretion. Concerning toxin inactivation, 
the French team abandons Pasteur’s dogma of lowering the virulence by 
exposure to oxygen or oxidants, and instead uses chemical attenuation of 
the toxin with iodine trichloride, a procedure inspired by Ehrlich’s work on 
iodine derivatives (who is quoted). The protocol of injection of increasing 
doses of the inactivated toxin into horses, then of pure toxin in order to 
prepare protective immune sera, is described in great detail. The health 
and behaviour of each injected horse is monitored in laboratory files 19, and 
several exemplary cases are reported in the paper. Roux acknowledges that 
preparation in horses of hyper-immune sera has been made in concordance 
with the work carried out in Germany: the quality of the production of 
serum by various animals had already been tested by German scientists, 
and the choice of horses as serum producers has been suggested by von 
Behring as a good compromise between the needs for large-scale produc-
 17. Jacques Joseph Grancher (1843-1907) a physician responsible for the department of infectious 
diseases at the Hôpital des enfants malades in Paris, was from the beginning a follower of Pasteur. 
A succinct biography can be found at: http://www.pasteur.fr/infosci/archives/f-bio.html
 18. Note de lecture des Annales de l’Institut Pasteur, 1893, 7, 833-837, signalant l’article de WERNICKE, 
Erich. Contribution à la connaissance du bacille diphtérique de Loeffler et à la sérothérapie. 
(Translation of the paper published in Archiv fur Hygiene, 1893, vol. 18). 
 19. Some of these records have been retained at the Archives de l’Institut Pasteur in Paris and at 
the Musée des applications de la recherche in Marnes-la-Coquette (France).
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tion, the lowest spontaneous toxicity of sera, and the highest protective 
efficacy. Vaccination of horses was initiated in 1891 by Edmond Nocard 
(1850-1903) at the veterinary school of Maisons-Alfort 20. Starting from the 
fall of 1894, serum production is organized in the annexe of the Institut 
Pasteur in Marnes-la-Coquette, near Paris 21. It is worth noting that the 
first 1894 paper written by Roux and Martin dealing with the preparation 
and testing of protective horse sera acknowledges not less than 23 major 
contributions by Ehrlich, Behring, Wernicke and Aronson on the topics. 
This obviously indicates an excellent knowledge of the German literature as 
expected from the general circulation of scientific information, but should 
also be taken primarily as the overt recognition of German contributions 
to the work carried out at the Institut Pasteur. 
The second 1894 article by Roux and Martin describes the results of 
a large-scale clinical trial using previously produced and characterized 
immune horse sera 22. The trial was carried out in Grancher’s ward at the 
Hôpital des Enfants-malades in Paris. Grancher had already been closely 
associated with Pasteur’s and Pasteurian work. His ward was devoted to the 
treatment of children with diphtheria and was organized accordingly 23. The 
selection of the test groups out of a large number of patients, as described 
in the paper presenting results of large-scale serotherapy (see below), was 
based on bacteriological criteria 24. There is no need to discuss once more 
the results communicated by Roux, first in Lille in the spring of 1894 and 
then at the International Congress of Hygiene in Budapest in September 
1894. It is worth noting that at the same meeting, Hans Aronson of Berlin 
reported identical results concerning the treatment of diphtheria patients. 
The stage of development reached was primarily the same at the Institut 
 20. Archives of the Ecole vétérinaire d’Alfort, kept at the Archives départementales du Val de Marne, 
Créteil. Some injections and bleeding may have been made on the Institut Pasteur campus 
(J. Simon personal communication).
 21. The initial name of the Annexe is domaine de Villeneuve l’Etang. A detailed study of the 
architecture and plans of the Marnes-la-Coquette production center and of their link with 
the medical project of Roux and Grancher is under preparation (Bottineau, Opinel, Rivoirard, 
Leniaud and Gachelin).
 22. ROUX, Emile; CHAILLOU, Auguste; MARTIN, Louis. Trois cents cas de diphtérie traités par le 
sérum anti-diphtérique. Annales de l’Institut Pasteur, 1894, 8, 640-661.
 23. OPINEL, note 12.
 24. CHAILLOU, Auguste; MARTIN, Louis. Étude clinique et bactériologique sur la diphtérie. Travail 
du laboratoire du Dr. Roux. Annales de l’Institut Pasteur, 1894, 8, 449-478.
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Pasteur and in the Hoechst factory in Germany 25. The two studies and 
the discussion that followed show a general consensus on the therapeutic 
method, as well as on the meaning of the numbers reported 26. The procee-
dings did not mention any critical discussion between German and French 
contributors concerning procedures and uses of serum against diphtheria, 
but rather noted a consensus. A consequence of that consensus is the ex-
tremely fast, world-wide diffusion of serotherapy and the development of 
the corresponding bio-industry. 
Insufficient statistical analysis is one of the weaknesses of Pasteur’s 
initial trials. An important step in the evaluation of a reagent for thera-
peutic use is the designing of adequate tests cohorts and proper statistical 
analysis of the results. Roux and Martin compared two cohorts of patients 
identically defined in terms of symptoms and nature of bacterial infections; 
subjective and social biases are, however, not excluded. In any case, that 
type of analysis fitted a use of statistics based on the direct comparison 
of numbers, which was rather common at the moment and was accepted 
by all participants of the meeting, including the Germans. The adverse 
effects of serum-therapy (serum sickness) were known 27 but neglected 
as considered minor. The genuinely positive effects of immune sera on 
diphtheria patients are finally proven in 1898, by a Danish physician of 
the Blegsdamhospitalet in Copenhagen, Johannes Fibinger (1867-1928) 28, 
in what, according to Chalmers, had been one of the first random trials in 
medical history 29. 
 25. See HÜTTELMAN, Axel. Diphtheria serum and serotherapy. Development, Production and 
Regulation in fin de siècle Germany, Dynamis, present issue. 
 26. Revue d’hygiène et de police sanitaire, 1894, 16, 784-798. 
 27. LANDOUZY, Louis. Sérothérapie. Leçons de thérapeutique et matière médicale, Paris, Georges Carré 
&C. Naud Editeurs, 1896.
 28. FIBIGER, Joannes. Om serumbehandling af difteria. Hospitalstidende, 1898, 6, 309-325 and 337-
350. The English translation of the lecture delivered by Fibiger at the Congress of Medicine at 
Moscow (30/11/1897)has been published in Bmjjournals.com/content/317/issue 7167. Fibiger‘s 
paper is discussed by HROBJARTSSON, A.; GOTZSCHE, C.; GLUUD, C. The controlled clinical 
trial turns 100 years: Fibiger’s trial of serum treatment of diphteria. British Medical Journal, 
1998, 317, 1243.
 29. CHALMERS, Ian. Comparing like with like: some historical milestones in the evolution of methods 
to create unbiased comparison groups in therapeutic experiments. British Medical Journal, 
1998, 317, 1167.
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3.  The designing of French standards and norms in accordance with 
German ones
In contrast with earlier articles on anthrax or rabies vaccines, the protocols 
concerning the isolation and inactivation of diphtheria toxin were exten-
sively described, making them easily reproducible elsewhere. The protocols 
of bacterial growth were progressively improved for better secretion of 
toxin in the supernatant of long-term cultures. A strain of Corynebacte-
rium diphteriae (strain nr 261) was selected as a high producer of toxin 
under specific growth conditions 30. This indicates an important move 
towards the use of reference strains for production instead of bacterial 
samples freshly isolated from patients and selected on the basis of their 
in vivo virulence. Accordingly, the methods used to control the sequential 
steps of the production and selection of serum by using in vivo assays on 
guinea pigs and rabbits were fully described. The French procedure was 
designed by Roux, but its basis had been established previously in Germany. 
The toxicity unit of diphtheria toxin was defined in vivo as the volume 
of supernatant which kills a 500-g guinea pig in 48 hours. This in turn 
enabled the definition of protective units. The description of that used 
by Roux and Martin in 1894 (one ml of horse serum able to neutralize 
20 ml of a toxin solution, 0.1ml of the latter killing a 500-g guinea pig in 
48 hours) was preceded by a one-page description of the three succes-
sive definitions of units used by Behring and Paul Ehrlich (1854-1915). 
The important point for the present analysis is the fact that protective 
units, although defined differently in France and in Germany, are linked 
by a simple proportionality factor, which facilitates the comparison of 
reagents. The need for international units is emphasized: Roux speculates 
that standardization would be of more general use if comparative studies 
could be carried out using Behring’s toxin and sera 31. Ehrlich and Roux 
first used a standardization based on the neutralization of the activity 
of the toxin (the amount of serum needed to neutralize 100 lethal doses 
of toxin). Because of the variability in toxicity of C. diptheriae culture 
supernatants, Ehrlich, and immediately after him, the Institut Pasteur, 
 30. DELAUNAY, Albert. L’Institut Pasteur des origines à aujourd’hui, Paris, Editions France-Empire, 1962, 
p. 326.
 31. ROUX, CHAILLOU, MARTIN, note 22.
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rapidly turned to the use of serum standards, more stable than toxin 
standards. The procedure was described in detail in the lectures on diph-
theria given by Roux and Martin to physicians 32. Finally, the quantity of 
serum to be administered to children was defined on a weight- (guinea 
pig) to-weight (child) basis, which implies that researchers admit that 
the human response to the serum was qualitatively and quantitatively 
identical to that of guinea pigs. The entire production and test process 
thus obeyed a defined and public protocol. Standardization of biological 
reagents had become an integral part of Pasteurian scientific culture as 
early as the beginning of 1894. The anti-diphtheria serum was a drug in 
standardized use in France at the beginning of 1895 33. The standardization 
of anti-diphtheria serum in France is definitively associated with the fact 
that German scientists had already worked out their own standards. Roux 
writes, «A vrai dire, nous n’attachons pas beaucoup d’importance à toutes 
ces definitions compliquées (…) Cependant il était nécessaire de parler de 
ces unités de mesure, puisqu’elles sont employées à chaque instant dans les 
travaux allemands» 34. Such a sentence is unambiguous concerning the 
compliance with German methods (in vivo assay on guinea pigs) and the 
approach to norms (definition of comparative units).
Up to that point, the table-tennis research on serotherapy has led to 
nearly identical results in the two countries. Later, divergence on the sero-
therapy issue between France and Germany is found in the choice between 
a state-controlled standardization and production of sera in Germany fo-
llowing Ehrlich’s proposals, and endorsement by state agencies of privately 
defined standardization and production of sera in France —private and 
placed under the auspices of the Institut Pasteur and its subsidiaries. This 
point is discussed elsewhere  35.
 32. Archives de l’Institut Pasteur, fonds Ramon, box RAM-42.
 33. Anti-diphtheria serum is registered in the Codex medicamentarius gallicus 1908; there was no 
Codex edition between 1884 and 1908.
 34. ROUX, CHAILLOU, MARTIN, note 22.
 35. GACHELIN, Gabriel. The development of anti-diphtheria serum-therapy at the Institut Pasteur: 
construction of a culture of standardization. In: Wertbestimmungen-Evaluations. Standardis-
ing therapeutic agents 1890-1930 [Christoph Gradmann, ed., in press]. See also the papers by 
Simon and Hüntelmann in the present issue of Dynamis.
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4.  The rapid decline of strong anti-German feelings at the Institut 
Pasteur
The last open conflict between Pasteur’s and Koch’s followers about scien-
tific issues appears to have occurred in 1887, still concerning the anthrax 
issue 36. In a few years after 1882, the attitude of French bacteriologists 
towards science produced in Germany is transformed into a scientific and 
probably, but insufficiently documented, economic race, at least as far as 
diphtheria is concerned. 
It appears from the diphtheria case that after 1887/1888, science around 
Pasteur becomes structured in such a way that it answers most of Koch’s 
criticisms. This may have been due in part to the fact that the two leaders 
have been rather left aside in the work on diphtheria, the leaders of which 
are now Roux in France and von Behring in Germany. In France, the Institut 
Pasteur is inaugurated in 1888. Its plans were supervised by Roux 37. The 
institute is designed so that all matters concerning the different aspects of 
microbiology could be dealt with within the same building. It was initially 
thought of as an anti-rabies institute and indeed possesses the proper space 
for consultation and preparation as well as a kennel outside of the main 
building. It was in fact, from the beginning thought out much more as an 
institute of general microbiology than as a rabies institute. Before that, 
research was carried out in Pasteur’s own laboratories and facilities at the 
Ecole Normale Supérieure under the close supervision of Pasteur. From 
1888 onwards, laboratory space is clearly allocated to heads of laboratories 
rather autonomously dealing with various aspects of microbiology. The 
scientists in charge of the different laboratories were nearly all in their 
40s or younger: Roux 35, Chamberland 36, Metchnikoff 42, Grancher 44; 
Yersin, the youngest, was 24 and Duclaux, the oldest, was 47. The dispen-
sary for rabies is placed under the supervision of Jacques Joseph Grancher, 
paediatrician associated with Pasteur from the beginning of the work on 
rabies. Thus, medical applications are physically and administratively set 
apart from research. Other highly significant changes concern the scientific 
and medical staff working at the new institute. Pasteur’s declining health 
forces him to gradually resign after 1887 from his official positions and 
 36. Conflicts related to commercial interests and distribution will not be discussed in the present 
paper.
 37. L’Institut Pasteur. Annales de l’Institut Pasteur, 1889, 3, 1-17.
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pushes Roux, at the age of 35 in 1888, towards leading intellectual and 
administrative positions within the Institut Pasteur 38. Duclaux is nomi-
nated Director in 1895, after Pasteur’s death; but evidence indicates that 
Roux is, along with Metchnikoff, the scientific leader of the Institute. The 
sudden taking over of research responsibilities at the Institut Pasteur by a 
rather young and primarily civilian staff (by comparison to Koch’s nearly 
exclusively army physician environment) is associated with an open attitude 
towards European, particularly German, science. The association of their 
respective training makes the Institut Pasteur a kind of multidisciplinary 
research centre. Roux, a former army physician who had left the army for 
insubordination, brings medical thinking into research that he conducts with 
a more rigorous approach to science than that of Pasteur. Metchnikoff, a 
zoologist of Ukrainian origin, had long stayed in several European laborato-
ries (1864-1866 in Germany: Heligoland with Kohn, Giessen with Leuckart; 
1867 in Naples with Kovalevsky; then from 1869 to 1873 in several marine 
laboratories in France, Spain and Italy in addition to Russia, which he left 
in 1888) and was very familiar with German laboratory life. He brings in a 
wealth of knowledge on diverse biological systems, including the defense 
of invertebrates against microbes. Yersin had first studied medicine in 
Marburg and attended Koch’s lessons in Berlin in 1889. Emile Duclaux 
(1840-1904) is a chemist and a biologist, a specialist of fermentations, and 
teaches at the university. Chamberland, a physician and biologist, was a 
close associate of Pasteur on the anthrax issue, and is sufficiently aware of 
German approaches to the issue to be sent to Germany in 1887 to discuss 
results with Koch and Loeffler 39.
The familiarity of Pasteurian scientists with German scientific life is 
also shown by the titles of the books in the institute’s library and by the 
coverage of foreign publications in the scientific journal the Annales de 
l’Institut Pasteur, launched in 1887 by Duclaux 40. Although the rationale 
for creating a new journal clearly was the promotion of the results obtained 
 38. In 1889, Roux, in addition to being the acting director of the Institute, was also in charge of the 
Cours de microbie technique, of his own laboratory (laboratoire de microbie technique) which 
included a group of photomicrography, and of the animal colony. DEA of LEGOUT, Sandra. 
La famille pasteurienne: le personnel scientifique permanent de l’Institut Pasteur de Paris entre 
1889 et 1914, Paris, EHESS, sept. 1999.
 39. CHAMBERLAND, Charles. Résultats pratiques de la vaccination charbonneuse. Annales de l’Institut 
Pasteur, 1887, 1, 301.
 40. The editorial board grouped Roux, Chamberland , Duclaux, Grancher, Nocard and Straus.
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at the Institut Pasteur and related institutions 41, the style of the papers was 
not polemical, and the Annales reported summaries of all works carried out 
elsewhere, particularly in Germany, that had appeared important enough 
to the editors. Other medical and scientific journals obviously have con-
tributed for long to the diffusion of scientific information: the interesting 
point here is that the process stems from the inside of the Institut Pasteur 
and thus reflects a local attitude 42. Indeed, in their papers concerning 
diphtheria, Roux and his colleagues discuss positively the successive and 
decisive contributions of their German colleagues. As already mentioned, 
the 1894, best-known paper written by Roux and Louis Martin (1864-1946) 
dealing with the preparation and testing of anti-diphtheria sera, is preceded 
by an extensive bibliography including papers published abroad and a de-
tailed analysis of the papers by Behring, Kitasato and co-workers on the 
production of sera able to neutralize bacterial toxins. Roux openly admits 
that Institut Pasteur’s team had greatly benefited from earlier work on the 
inactivation of toxins and selection of the most suitable animals for vac-
cine production. He acknowledges German contributions by writing «Nous 
pouvons declarer que nos résultats confirment, dans ce qu’ils ont d’essentiel, 
ceux de M. Behring et de ses collaborateurs» 43. The existence, at the same 
moment, of close and collaborative contacts (exchange of bacterial strains, 
sera and various reagents) between German and French microbiologists 
extends beyond the diphtheria case, as shown by a recent study on the 
endotoxin-anti-endotoxin issue 44. Over a period extending from 1885 to 
1905, Metchnikoff, first in Odessa, then in Paris, and A. Besredka (1870-
1940, a Ukrainian-born scientist who moved with Metchnikoff to Paris and 
succeeded him in 1916), on one side and R. Pfeiffer (1858-1945) in Koch’s 
laboratory, on the other side, though conflicting on the issue, nevertheless 
 41. The first article of the first issue of the Annales is a letter by L. Pasteur developing the success 
of the anti-rabies vaccination. Lettre de M. Pasteur sur la rage. Annales de l’Institut Pasteur, 
1887, 1, 1-18.
 42. That trend is further developed later. The Bulletin de l’Institut Pasteur, launched in 1903, 
exclusively contains reviews of scientific papers published elsewhere. It is an informative 
source of what was considered important for the medical and biological communities. The 
German contributions are largely quoted.
 43. ROUX, Emile; MARTIN, Louis. Contribution à l’étude de la diphterie (serum-thérapie). Annales 
de l’Institut Pasteur, 1894, 8, 609.
 44. RIETSCHEL, Ernst; CAVAILLON, Jean-Marc.Endotoxin and anti-endotoxin: The contribution of the 
schools of Koch and Pasteur: Life, milestone-experiments and concepts of Richard Pfeiffer 
(Berlin) and Alexandre Besredka (Paris). .J. Endotoxin Res., 2002, 8, 71-82.
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cooperated over the existence of anti-endotoxin antibodies able to neutralize 
endotoxins, an important issue in the emerging field of innate immunity. 
Institut Pasteur scientists did not hesitate to attend meetings in Germany, 
an attitude contrasting with that of Pasteur. French microbiology was thus 
inserted differently into the European landscape of the discipline, which 
to a certain extent means the sharing of methods and concepts, not to say 
the ability to use the same language. 
Part of the change in attitude towards German science is also likely to 
have been associated with the political and social convictions of some of 
the main scientific leaders of the Institut Pasteur. Pasteur had been dee-
ply engaged in political circles of the Second Empire, and was politically 
conservative and strongly anti-German. By contrast, as mentioned, Roux’s 
statements did not show chauvinistic attitudes. Roux’s letters to Metchnikoff 
are explicit on that point, and Roux expresses his opposition to anti-Ger-
man campaigns concerning the attendance at meetings in Germany. Also 
in his letters, over a period of 15 years, Roux several times expresses his 
admiration and confidence in Koch 45. Roux, Metchnikoff and Behring 
were friends to the point that Roux and Metchnikoff were the godfathers 
of Behring’s sons 46. Behring and Metchnikoff freely exchanged scientific 
information on various subjects including work in progress 47. On the 
political side, Roux defended Alfred Dreyfus at least at the moment of the 
revision trial of 1899 48. Duclaux was more of a pacifist, very sensitive to 
human rights problems. He also defended Dreyfus as early as 1898 and 
contributed to the creation of «La ligue des droits de l’homme et du cito-
yen», of which he became vice-president. Chamberland had been elected 
Deputy to the parliament in 1885 and belonged to the républicain radical 
group and proved active in defending laws on hygiene. Metchnikoff was 
a convinced socialist and pacifist and experienced serious problems with 
the tsarist administration in Odessa. 
Research facilities and access to teaching at the Institut Pasteur were 
largely open to foreigners. Many foreign physicians attended the Cours de 
 45. Archives de l’Institut Pasteur (AIP), Fund MTC2, letter of Roux to Metchnikoff 19 August 1890.
 46. Correspondence between Metchnikoff and Behring, and Roux to Metchnikoff, AIP, Fund 
MTC2.
 47. AIP, Fund MTC2 correspondence Behring-Metchnikoff.
 48. AIP, Fund Metchnikoff, file 2, letters of Roux to Metchnikoff dated August 16, September 7 and 
12, 1899, concerning the Rennes trial. 
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microbie technique created by Roux in 1888. Metchnikoff, who spoke several 
foreign languages, opened his laboratory to researchers of many countries 
(at least 20 different countries of origin were listed from 1888, date of the 
founding of the laboratory, until Metchnikoff ’s death in 1916 49). During the 
period of time considered (ca 1890 to ca 1900), a minimum of 8 German 
scientists spent a year or more at the Institut Pasteur, predominantly in 
Metchnikoff ’s and Roux’ laboratories. That number, though small compa-
red to the number of Russians, is nevertheless equivalent to the number of 
British scientists (about 9). Among the German scientists having worked 
in Roux’s laboratory, the presence of Hermann Duenschmann is worthy 
of note. He spent 2 years (1893-1894) working on black-leg disease and 
published a paper in The Annales de l’Institut Pasteur reporting attempts 
to prepare a curative antiserum against the disease 50. It is also worth no-
ting that he developed a technique of immunization using organ filtrates, 
which remained in use by Roux for years 51 . Dueschmann also worked on 
megacytes and reported discussions with Metchnikoff and people from his 
laboratory. Thus, in contrast to what had been the Pasteur laboratory at the 
rue d’Ulm, the Institut Pasteur quite rapidly moved towards being a kind 
of international institution in which Metchnikoff and Roux most probably 
played a dominant role. In other words, the years 1885-1890 constituted a 
kind of rapid transition period from the «heroic age» towards an open and 
international approach of microbiology and science in general. Foreign vi-
siting scientists worked at the bench along with their French colleagues. 
As a consequence, research in microbiology at the Institut Pasteur had 
adopted some of the important issues of Koch’s and coworkers’ laboratory, 
namely methods, quantification of reagents and norms, while keeping to its 
original «host-microbe relationship» approach to infectious diseases, whi-
ch led to the subsequent development of immunology. The same motives 
that had made German microbiology «palatable» and had to some extent 
transformed the Pasteurian approach to microbiology, had converted the 
Institut Pasteur into a genuinely international structure, on the one hand 
 49. LEGOUT, note 38.
 50. DUENSCHMANN, Hermann. Étude expérimentale sur le charbon asymptomatique. Annales de 
l’Institut Pasteur, 1894, 8, 403-434.
 51.  Quoted and discussed in Blackleg vaccines: their production and use, Kansas State Agricultural 
Experiment Station, Technical Bulletin 10, June 1923, Topeka , Kansas, 1923.
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strengthening its influence abroad, on the other hand benefiting from a 
flow of foreign experience, models and diseases. 
The place given by the Institut Pasteur to German science as a model 
and as a competitor extended to other fields of research such as chemistry 
and biological chemistry. Duclaux, who shared with Roux the opinion that 
microbiology and fermentations had to be placed in close contact with re-
search in organic chemistry, sent a chemist, Gabriel Bertrand (1867-1962), 
to study that very problem in Germany. The conclusion of the mission of 
Bertrand 52, who stayed in Germany in 1897, resulted in the construction of 
the biological chemistry building dedicated in 1901. Concerning chemistry, 
a recent analysis of the history of therapeutic chemistry in France made by 
Debue-Barazer extends the conclusions reached in microbiology to thera-
peutic chemistry at the Institut Pasteur 53. Ernest Fourneau (1872-1949) a 
pharmacist, escaped the tradition of Berthelot’s chemistry by being trained 
in Germany, first in Heidelberg in 1899 with L. Gattermann (1860-1921), 
a specialist in the synthesis of organic molecules, then in Berlin in the 
laboratory of Emil Fisher (1852-1919), a former student of A. von Bayer, 
also a specialist in the synthesis of organic molecules including peptides, 
and finally in Munich in Richard Willstätter’s laboratory in 1901, where 
he studied the structure and synthesis of alkaloids. Fourneau came back 
to France in 1902 and moved to the Institut Pasteur soon after, at Roux’s 
request. He then created the laboratory of therapeutic chemistry, largely 
inspired in its methods and research themes by his German experience. 
As for anti-diphtheria serotherapy, the syntheses of organic molecules by 
Fourneau and co-workers paralleled syntheses carried out in German labo-
ratories and showed a similar convergence and rivalry between the Institut 
Pasteur associated with Rhone-Poulenc, and the German laboratories and 
firms, concerning arsenic derivatives used against malaria, sleeping sickness 
and syphilis, and derivatives of alkaloïds used for anaesthesia, to keep to the 
period of time we have considered 54. Debue-Barazer concludes that this 
was not mimicry or copying of German chemistry on the part of Fourneau 
but rather the rational use of what had been learned to develop one’s own 
 52. Gabriel Bertrand (1867-1962), biologist and chemist, created the laboratory of biological che-
mistry at the Institut Pasteur. He is the discoverer of oligo-elements.
 53. DEBUE-BARAZER, Christine. Quand l’admiration d’une culture conduit à l’innovation thérapeu-
tique. Ernest Fourneau et les Allemands, Gesnerus, 2007 (in press).
 54. DEBUE-BARAZER, note 53.
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way of research. The biological chemistry building was a combination of 
laboratories organized in a manner reminiscent of that suggested by L. 
Hugounenq in his 1898 report on the teaching of medical chemistry in 
Germany 55. The «Pasteurian touch» to that construction was brought by 
the addition of a hospital devoted to infectious diseases according to Roux’s 
general plan for the Institute 56.
Classical historiography presents the attitude of France towards 
Germany after the Franco-Prussian war of 1870 as dominated by an ob-
session for revenge. Keeping to the scientific domain, to a certain extent 
the Koch-Pasteur dispute can be viewed in that way. Concerning science 
and universities in general, the reality appears somewhat different, and 
the history of serum-therapy, like that of anti-endotoxin sera and organic 
syntheses later, are to be placed in the more general context of their rela-
tions during the last third of the 19th century 57. The opinion that France 
had been defeated by Prussian science, industry and technology was used 
as a strong argument for reforming French universities in 1885 largely 
following the German model 58. The place of the German model in the 
organization of universities, teaching and research in France has recently 
been extensively analysed by Charle 59. This was not anything new at the 
end of the 19th century. The relative decline of the place occupied by French 
research in general among European universities had been observed since 
1860, particularly by chemists 60. The creativity of French chemistry was 
declining since the middle of the 19th century and, as Wurtz noted before 
the Franco-Prussian war, Germany was the place organic syntheses were 
getting shaped 61. The situation was preoccupying enough to send missions 
to Germany as early as 1866 in order to study the organization of German 
universities assumed to be at the origin of German military, scientific and 
 55. HUGOUNENQ, Léon. L’enseignement de la chimie médicale en Allemagne et en France. Revue 
internationale de l’enseignement, 1897, 33, 97-105. 
 56. OPINEL, note 12.
 57. PAUL, Harry W. The sorcerer’s apprentice: the French scientist’s image of German Science, 1840-1919, 
Gainesville, University of Florida Press, 1972 and DIGEON, Claude. La crise allemande de la 
pensée française, 1870-1914, Paris, Presses Universitaires de France, 1992. 
 58. WEISZ, Georges The emergence of modern universities in France, Princeton, Princeton University 
Press, 1983.
 59. CHARLE, Christophe. La république des universitaires 1870-1940, Paris, Editions du Seuil, 1994.
 60. PAUL, note 57.
 61. PAUL, Harry W. From knowledge to power: the rise of the science empire in France 1860-1939, Cam-
bridge, Cambridge University Press, 1985.
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economic successes. The shock of defeat and the causes attributed to it 
prompted the resumption of missions to Germany, as early as 1877, all 
of them followed by the writing of reports largely publicized in issues of 
the Revue internationale de l’enseignement. Nearly all of the reports were 
enthusiastic about the quality of research and teaching in German univer-
sities, as well as about the quality of the relations between professors and 
students. This was not limited to biology and chemistry. A very similar 
reciprocal transfer of knowledge between Germany and France has recently 
been noted in experimental psychology 62. German universities were in-
deed used as a starting point to reform the higher education and research 
system in France. Microbiology, experimental biology and chemistry are 
merely mentioned in Charle’s studies, with the exception of some aspects of 
Caullery’s report on zoology 63. The case of the Institut Pasteur partly fills 
in the gap. It indicates that German science has certainly acted as a model 
and the attitude of Pasteurian scientists was not any different from that of 
other university professors. The German way of doing science was known 
of Pasteurian scientists and was adapted to their own specific goals and 
approaches. Analysis of laboratory practices, rather, shows a reciprocal use 
of the data obtained on both sides in a kind of epistemology «in progress» 
aimed at designing specific biological and chemical reagents. The harsh 
discussions between German and French scientists contributed significantly 
and positively to improving emerging concepts and practices as well as to 
setting up norms and standards for biological reagents. ❚
 62. CARROY, Jacqueline; SCHMIDGEN, H. Reaktionsversuche in Leipzig, Paris und Würzburg: Die 
deutsch-französische Geschichte eines psychologischen Experiments, 1890-1910. Medizi-
nhistorisches Journal, 2004, 39, 27-55 (English preprint available from the Max Planck Institut 
für Wissenschaftgeschichte, Berlin).
 63. CAULLERY, Maurice. La zoologie dans les universités allemandes. Revue internationale de l’ensei-
gnement, 1894, 27, 398-420.
